Bing Xia Selected Research

Bing Xia Research Topics

Disease

77	Neoplasms (Cancer) 01/2024 - 11/2005
27	Ulcerative Colitis 02/2016 - 04/2004
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2024 - 01/2016
20	Inflammation (Inflammations) 12/2023 - 03/2004
18	Colitis 03/2022 - 03/2004
17	Breast Neoplasms (Breast Cancer) 10/2023 - 05/2007
14	Lung Neoplasms (Lung Cancer) 01/2024 - 09/2012
14	Infections 08/2020 - 12/2002
14	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 03/2007
11	Crohn Disease (Crohn's Disease) 03/2015 - 04/2004
10	Neoplasm Metastasis (Metastasis) 03/2022 - 02/2011
9	Stomach Neoplasms (Stomach Cancer) 01/2016 - 02/2005
8	Ovarian Neoplasms (Ovarian Cancer) 09/2020 - 08/2002
7	Hypoxia (Hypoxemia) 02/2023 - 06/2014
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2018 - 05/2012
6	Bites and Stings (Sting) 03/2024 - 01/2022
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2020 - 02/2012
5	Carcinogenesis 01/2023 - 02/2007
5	Nasopharyngeal Carcinoma 12/2016 - 07/2006
5	Virus Diseases (Viral Diseases) 08/2015 - 01/2013
5	Gastritis 02/2014 - 02/2005
4	Neuroinflammatory Diseases 12/2023 - 04/2020
4	Adenocarcinoma 01/2023 - 05/2004
4	Disease Progression 01/2022 - 01/2020
4	Fibrosis (Cirrhosis) 01/2022 - 03/2015
4	Genomic Instability 01/2020 - 10/2017
4	Hypersensitivity (Allergy) 08/2014 - 02/2007
4	Necrosis 11/2011 - 03/2006
4	Peptic Ulcer (Peptic Ulcers) 08/2009 - 02/2005
4	Muscular Dystrophies (Muscular Dystrophy) 02/2004 - 04/2002
3	Radiation Pneumonitis 01/2024 - 12/2018
3	Obesity 12/2023 - 03/2007
3	Insulin Resistance 06/2023 - 01/2019
3	Intestinal Diseases (Diseases, Intestinal) 05/2023 - 05/2022
3	Intervertebral Disc Degeneration 02/2023 - 01/2022
3	Diarrhea 01/2022 - 01/2013
3	Body Weight (Weight, Body) 11/2021 - 01/2013
3	Carcinoma (Carcinomatosis) 10/2021 - 06/2015
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2015
3	Salmonella Infections (Salmonellosis) 08/2020 - 05/2019
3	Multiple Myeloma 12/2018 - 10/2014
3	Wounds and Injuries (Trauma) 09/2016 - 01/2012

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2002
23	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 05/2007
19	Messenger RNA (mRNA)IBA 12/2019 - 03/2006
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2004
8	SiliconIBA 01/2023 - 08/2014
8	Tyrosine Kinase InhibitorsIBA 05/2021 - 01/2016
8	CytokinesIBA 01/2021 - 02/2010
8	micaIBA 06/2012 - 10/2005
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2011
7	ErbB Receptors (EGF Receptor)IBA 05/2021 - 01/2016
5	Therapeutic UsesIBA 11/2022 - 03/2006
5	Small Interfering RNA (siRNA)IBA 04/2022 - 03/2009
5	LigandsIBA 02/2021 - 04/2011
5	AntibodiesIBA 01/2016 - 03/2003
5	AntigensIBA 09/2015 - 03/2003
5	Folic Acid (Vitamin M)FDA LinkGeneric 09/2015 - 05/2007
5	Interleukin-10 (Interleukin 10)IBA 01/2014 - 07/2009
5	Peroxidase (Myeloperoxidase)IBA 01/2013 - 03/2006
4	Volatile Fatty AcidsIBA 03/2024 - 04/2020
4	InterferonsIBA 03/2024 - 12/2012
4	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2022 - 01/2013
4	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 09/2014
4	Epidermal Growth Factor (EGF)IBA 02/2021 - 10/2011
4	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2020 - 10/2018
4	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 03/2015
4	Sulfonic AcidsIBA 01/2014 - 03/2006
4	AcidsIBA 02/2013 - 03/2004
4	HomocysteineIBA 01/2012 - 05/2007
4	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2011 - 05/2007
4	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 08/2010 - 05/2007
3	InflammasomesIBA 11/2023 - 01/2022
3	Nerve Growth Factors (Neurotrophins)IBA 06/2023 - 01/2019
3	Oxygen (Dioxygen)IBA 02/2023 - 01/2020
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2022 - 11/2017
3	MicroRNAs (MicroRNA)IBA 10/2021 - 10/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021 - 01/2021
3	UbiquitinIBA 01/2020 - 09/2017
3	olaparibIBA 01/2020 - 11/2017
3	Caspase 3 (Caspase-3)IBA 01/2019 - 11/2011
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2019 - 03/2015
3	Bortezomib (Velcade)FDA Link 12/2018 - 06/2015
3	ParaffinIBA 01/2018 - 07/2013
3	Long Noncoding RNAIBA 01/2018 - 06/2015
3	Gefitinib (Iressa)FDA Link 05/2017 - 01/2016
3	idelalisibIBA 12/2015 - 10/2014
3	EnzymesIBA 12/2014 - 05/2004
3	3' Untranslated Regions (3' UTR)IBA 01/2013 - 12/2006

Therapy/Procedure

48	Therapeutics 01/2024 - 11/2005
20	Radiotherapy 07/2024 - 02/2012
14	Drug Therapy (Chemotherapy) 10/2023 - 02/2012
9	Immunotherapy 11/2023 - 12/2012
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 01/2015
5	Chemoradiotherapy 01/2024 - 09/2013
4	Photothermal Therapy 01/2021 - 01/2017
4	Aftercare (After-Treatment) 10/2019 - 10/2015
3	Oral Administration 01/2022 - 05/2019
3	Hematopoietic Stem Cell Transplantation 12/2018 - 10/2018